Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting ...

MD/Process MitoThrive's Clinically Researched NAD+ Booster with Nicotinamide Riboside, Apigenin, and Glutathione to Support ...

Advt "Successful PE exits with strong returns, such as Advent International's USD 1.6 billion sale of BSV Group to Mankind Pharma, have also validated India's buyout market, making it more ...

Shannon Sharpe, a former National Football League star and ESPN host, is being sued for $50 million for r*pe and battery charges. The woman who is being referred to as Jane Doe filed the case on April ...

"Anti-GPRC5D CAR T-cell therapy showed superior efficacy over CD38 antibody-based, carfilzomib [Kyprolis]-based, and selinexor [Xpovio]-based therapies in the study. Early initiation of anti ...

The university is the 27th largest PE investor in the world with over $20 billion invested in the asset class, according to affiliate title Private Equity International’s Global Investor 150 2024 ...

Law firms backed by private equity (PE) have seen revenue growth of 30% in the last two years, twice the rate of the top 50, according to new research. Accountants Hazlewoods said this suggested that ...

HexaBody-CD38 was a failed succession plan. Patent expiration is a common risk in the Biotech sector with the potential to dramatically erode a company's revenue and market value. Pharmaceutical ...

Finally, there’s NY-338, a CD38/NKp46 bifunctional antibody for the treatment of multiple myeloma that’s also expected to enter human trials in 2026. As part of its strategic change in ...